Valtrex Clinical Trials Valtrex RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
Condition:   Glioma, Malignant Interventions:   Biological: AdV-tk;   Drug: Valacyclovir;   Radiation: Radiation;   Drug: Temozolomide;   Biological: Nivolumab;   Other: Laboratory Biomarker Analysis Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Advantagene, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2018 Category: Research Source Type: clinical trials

GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
Condition:   Glioma, Malignant Interventions:   Biological: AdV-tk;   Drug: Valacyclovir;   Radiation: Radiation;   Drug: Temozolomide;   Biological: Nivolumab;   Other: Laboratory Biomarker Analysis Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Advantagene, Inc. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2018 Category: Research Source Type: clinical trials